Composition comprising gdnf and tgf-β1 and use thereof for the treatment of a neurological disease

作者: Emilio Fernández Espejo , Ramiro José González Aparicio

DOI:

关键词: MedicinePharmacologyInvoluntary movementDiseaseNeurotrophic factorsGlial cell line-derived neurotrophic factorTransforming growth factor

摘要: Pharmaceutical composition comprising the glial-derived neurotrophic factor (GDNF) and transforming beta 1 (TGF-β1) in a range of GDNF:TGF-β concentrations from 2:1 to 4:1. Moreover present invention relates use said pharmaceutical for preparation medicament treatment neurological disease. Preferably disease is neurodegenerative Said may with dyskinesias or other abnormal involuntary movements. Parkinson's

参考文章(5)
Emilio Fernández Espejo, Fadwa El Banoua, Isabel Caraballo Ramos, Beatriz Galán Rodríguez, Juan A. Flores Cordero, Trasplante de células naturales 'dopaminotróficas': nuevo concepto terapéutico antiparkinsoniano Revista De Neurologia. ,vol. 36, pp. 540- 544 ,(2003) , 10.33588/RN.3606.2002588
Kerstin Krieglstein, Prisca Henheik, Lilla Farkas, Jozsef Jaszai, Dagmar Galter, Knut Krohn, Klaus Unsicker, Glial Cell Line-Derived Neurotrophic Factor Requires Transforming Growth Factor-β for Exerting Its Full Neurotrophic Potential on Peripheral and CNS Neurons The Journal of Neuroscience. ,vol. 18, pp. 9822- 9834 ,(1998) , 10.1523/JNEUROSCI.18-23-09822.1998
B. Galan-Rodriguez, A. del-Marco, J.A. Flores, S. Ramiro-Fuentes, R. Gonzalez-Aparicio, I. Tunez, I. Tasset, E. Fernandez-Espejo, Grafts of extra-adrenal chromaffin cells as aggregates show better survival rate and regenerative effects on parkinsonian rats than dispersed cell grafts. Neurobiology of Disease. ,vol. 29, pp. 529- 542 ,(2008) , 10.1016/J.NBD.2007.11.009
Rolf Bechtold, Klaus Unsicker, Michael Paulista, Jens Pohl, Cytokines having neurotrophic activity ,(1998)